D

DaShenLin Pharmaceutical Group Co Ltd
SSE:603233

Watchlist Manager
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Watchlist
Price: 16.12 CNY -3.88% Market Closed
Market Cap: 18.3B CNY
Have any thoughts about
DaShenLin Pharmaceutical Group Co Ltd?
Write Note

DaShenLin Pharmaceutical Group Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

DaShenLin Pharmaceutical Group Co Ltd
Cost of Revenue Peer Comparison

Comparables:
603883
603939
301017
002727
A
301408

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
D
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Cost of Revenue
-ÂĄ17B
CAGR 3-Years
-21%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
LBX Pharmacy Chain JSC
SSE:603883
Cost of Revenue
-ÂĄ15.1B
CAGR 3-Years
-15%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Yifeng Pharmacy Chain Co Ltd
SSE:603939
Cost of Revenue
-ÂĄ14.7B
CAGR 3-Years
-19%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
Cost of Revenue
-ÂĄ6.6B
CAGR 3-Years
-27%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
Cost of Revenue
-ÂĄ12.3B
CAGR 3-Years
-14%
CAGR 5-Years
-15%
CAGR 10-Years
-18%
A
Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
Cost of Revenue
-ÂĄ2.6B
CAGR 3-Years
-29%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is DaShenLin Pharmaceutical Group Co Ltd's Cost of Revenue?
Cost of Revenue
-17B CNY

Based on the financial report for Jun 30, 2024, DaShenLin Pharmaceutical Group Co Ltd's Cost of Revenue amounts to -17B CNY.

What is DaShenLin Pharmaceutical Group Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-23%

Over the last year, the Cost of Revenue growth was -14%. The average annual Cost of Revenue growth rates for DaShenLin Pharmaceutical Group Co Ltd have been -21% over the past three years , -23% over the past five years .

Back to Top